Eli Lilly and Co (LLY)
762.66
+8.49
(+1.13%)
USD |
NYSE |
Mar 18, 16:00
762.50
-0.16
(-0.02%)
After-Hours: 20:00
Eli Lilly Price: 762.66 for March 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 18, 2024 | 762.28 | 769.68 | 758.25 | 762.66 | 2.489M |
Mar 15, 2024 | 755.38 | 760.89 | 747.71 | 754.17 | 3.711M |
Mar 14, 2024 | 764.95 | 768.00 | 749.40 | 760.73 | 2.648M |
Mar 13, 2024 | 757.00 | 760.77 | 745.71 | 757.84 | 2.357M |
Mar 12, 2024 | 740.96 | 755.97 | 738.01 | 754.95 | 2.702M |
Mar 11, 2024 | 752.21 | 756.80 | 727.62 | 734.37 | 3.969M |
Mar 08, 2024 | 780.00 | 780.00 | 755.00 | 762.14 | 4.055M |
Mar 07, 2024 | 771.84 | 792.99 | 761.12 | 780.16 | 3.977M |
Mar 06, 2024 | 784.29 | 787.85 | 774.00 | 779.77 | 2.519M |
Mar 05, 2024 | 785.31 | 788.53 | 769.28 | 777.59 | 3.169M |
Mar 04, 2024 | 796.44 | 800.78 | 786.16 | 792.28 | 3.856M |
Mar 01, 2024 | 769.02 | 784.08 | 764.13 | 782.12 | 4.248M |
Feb 29, 2024 | 753.08 | 756.46 | 744.02 | 753.68 | 3.905M |
Feb 28, 2024 | 762.25 | 763.00 | 751.66 | 757.64 | 2.716M |
Feb 27, 2024 | 754.90 | 772.95 | 745.44 | 765.00 | 2.717M |
Feb 26, 2024 | 771.30 | 780.22 | 769.12 | 771.92 | 2.244M |
Feb 23, 2024 | 774.00 | 777.65 | 762.26 | 769.54 | 2.395M |
Feb 22, 2024 | 763.58 | 775.12 | 756.27 | 769.64 | 3.167M |
Feb 21, 2024 | 738.08 | 749.50 | 733.24 | 745.91 | 3.549M |
Feb 20, 2024 | 790.00 | 793.38 | 753.20 | 755.66 | 4.701M |
Feb 16, 2024 | 771.03 | 794.47 | 763.50 | 782.06 | 5.009M |
Feb 15, 2024 | 755.80 | 762.99 | 750.01 | 757.78 | 2.507M |
Feb 14, 2024 | 745.82 | 764.05 | 745.00 | 757.31 | 3.394M |
Feb 13, 2024 | 730.18 | 742.98 | 730.18 | 742.97 | 2.860M |
Feb 12, 2024 | 740.80 | 740.80 | 726.45 | 737.26 | 2.932M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
106.79
Minimum
Jul 19 2019
792.28
Maximum
Mar 04 2024
276.35
Average
240.31
Median
Feb 18 2022
Price Benchmarks
Regeneron Pharmaceuticals Inc | 959.72 |
Madrigal Pharmaceuticals Inc | 283.07 |
Vertex Pharmaceuticals Inc | 411.10 |
Viking Therapeutics Inc | 63.35 |
Moderna Inc | 104.28 |
Price Related Metrics
PE Ratio | 134.12 |
PS Ratio | 20.17 |
Price to Book Value | 67.27 |
Earnings Yield | 0.75% |
Market Cap | 724.65B |
Operating PE Ratio | 62.46 |
Normalized PE Ratio | 83.17 |